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Melanocytes are pigment-producing cells of neural
crest (NC) origin that are responsible for protecting
the skin against UV irradiation. Pluripotent stem cell
(PSC) technology offers a promising approach for
studying human melanocyte development and dis-
ease. Here, we report that timed exposure to activa-
tors of WNT, BMP, and EDN3 signaling triggers the
sequential induction of NC and melanocyte precur-
sor fates under dual-SMAD-inhibition conditions.
Using a SOX10::GFP human embryonic stem cell
(hESC) reporter line, we demonstrate that the tempo-
ral onset of WNT activation is particularly critical
for human NC induction. Subsequent maturation of
hESC-derived melanocytes yields pure populations
that match the molecular and functional properties
of adult melanocytes. Melanocytes from Herman-
sky-Pudlak syndrome and Chediak-Higashi syn-
drome patient-specific induced PSCs (iPSCs)
faithfully reproduce the ultrastructural features of
disease-associated pigmentation defects. Our data
define a highly specific requirement for WNT
signaling during NC induction and enable the gener-
ation of pure populations of human iPSC-derived
melanocytes for faithful modeling of pigmentation
disorders.INTRODUCTION
Epidermal melanocytes are pigment-producing cells found at
the basement membrane of the skin, where they establish a pho-
toprotective barrier against UV irradiation. Melanocytes synthe-
size melanin within specialized lysosome-related structures
known as melanosomes, which are subsequently transferred
to neighboring keratinocytes, giving the skin its characteristic
pigmentation. Although the developmental biology of melano-
cytes has been well studied in avian andmurine models, the pro-1140 Cell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authorscesses underlying melanocyte development in humans remain
poorly understood. The derivation of melanocytes from human
embryonic stem cells (hESCs) therefore provides a valuable
tool for studying human melanocyte development and modeling
disease biology. Previous work on the derivation of melanocytes
from murine (Yamane et al., 1999) and human (Fang et al., 2006;
Nissan et al., 2011) ESCs relied on stromal coculture or embryoid
body formation in combination with conditioned media from a
WNT3a-producing stromal cell line to trigger melanocytic differ-
entiation. The lack of a defined culture system has complicated
efforts to gain better mechanistic insights into early melanocyte
development and maturation.
During development, melanocytes arise from a transient,
migratory population of cells that are unique to vertebrates and
known as the neural crest (NC). The NC is a multipotent popula-
tion that exhibits a broad differentiation repertoire with distinct
fate potentials along axial levels of origin. Our laboratory previ-
ously established a stromal-coculture-based approach for
differentiating hESCs into NC with peripheral nervous system
(PNS) and mesenchymal competence; however, this population
did not efficiently yield melanocyte lineages (Lee et al., 2007).
More recently, a neural induction protocol in which hESCs are
differentiated under defined dual-SMAD-inhibition (DSi) condi-
tions was found to support low levels of spontaneous NC induc-
tion (Chambers et al., 2009) and the emergence of a pigmented
cell population. However, most pigmented cells under those
conditions exhibit properties of CNS-derived retinal pigment
epithelium rather than melanocyte lineage (see Figure S2).
Therefore, we sought to establish a novel, defined approach
for the derivation of a melanocyte-competent NC population
that would enable us to dissect the mechanistic and temporal
signaling requirements underlying NC induction, specification
along the melanocyte lineage, and melanocyte maturation.
We now report that activation of canonical WNT signaling is
sufficient to drive efficient NC specification at the expense of
CNS lineages under defined, DSi-based neural induction condi-
tions. We found that a brief pulse of WNT activation is sufficient
to induce NC with high efficiency. Remarkably, induction is
largely insensitive to pharmacological BMP inhibition and is not
dependent on sustained WNT activity. However, derivation of
the melanoblast lineage required additional exposure to BMP4
Figure 1. Induction and Isolation of NC from
Sox10::GFP hESCs Using a Modified DSi
Protocol
(A) A DSi protocol can be modified to support
highly efficient induction of an NC population by
optimizing BMP, TGF-b, and Wnt signaling.
(B) NC conditions support induction of a
Sox10::GFP-expressing population that coex-
presses the NC markers HNK-1 and p75 while
downregulating ZO-1- and PAX6-expressing CNS.
Scale bars represent 200 mm.
(C) NC-optimized conditions increase the yield of
Sox10::GFP-positive cells by >20-fold (53% ±
14%, n = 4, p = 0.002) over the DSi condition.
(D) Using FACS analysis, Sox10::GFP was first
detected at day 6 of NC differentiation and peaked
by day 11. Sox10::GFP induction efficiency is
represented as a percentage of total viable cells.
(E) Significantly upregulated (green) or down-
regulated (red) genes at day 11 in NC-induced cells
compared with DSi cells. Bold genes represent the
top ten most differentially regulated genes.
All error bars represent the SEM of at least three
independent experiments. **p < 0.01. See also
Figures S1 and S2.and EDN3 to induce KIT+ melanocyte-competent NC precur-
sors. We describe defined and scalable culture conditions for
the subsequent differentiation, maturation, and long-term main-
tenance of hESC-derived melanocytes. Finally, we confirm the
robustness and utility of our melanocyte differentiation paradigm
by modeling pigmentation defects in two independent genetic
disorders using patient-specific induced pluripotent stem cells
(iPSCs). Differentiation into melanocytes, across all control and
disease-specific iPSCs, displayed minimal variability. Further-
more, a direct comparison of disease and control lines identified
discrete defects in melanosome loading and transfer by ultra-
structural analysis. Our results offer insights into human NC
and melanocyte specification, and present a defined and effi-
cient protocol for generating human melanocytes from PSCs
that faithfully reproduce patient-specific pigmentation defects.
RESULTS
Derivation of NC from hESCs
To recapitulate the progressive differentiation that occurs during
normal development, we established a stepwise differentiation
protocol in which human PSCs (hPSCs) are first differentiated
to the multipotent NC stage before becoming melanoblast pre-
cursors capable of maturing into terminally differentiated mela-
nocytes. In the DSi protocol, hESCs are treated for 11 days
with two small molecules that inhibit the separate branches ofCell Reports 3, 1140–11SMAD signaling: LDN-193189 (LDN),
which inhibits BMP signaling, and
SB431542 (SB), which inhibits transform-
ing growth factor b (TGF-b), Activin, and
Nodal signaling (Figure 1A). Inhibition of
both arms is required to trigger exit from
the pluripotent state, prevent trophecto-derm formation, and block the formation of mesendoderm and
nonneural ectoderm (Chambers et al., 2009). However, NC spec-
ification requires intermediate levels of BMP signaling (Marchant
et al., 1998), whereas activation of TGF-b signaling is thought to
be required at a later time point to promote the epithelial-to-
mesenchymal transition (Xu et al., 2009). To reconcile these
opposing requirements, we hypothesized that withdrawal of
BMP and TGF-b inhibitors at intermediate time points might
allow early inhibition of alternate lineages while facilitating NC
specification at later stages by restoring endogenous BMP and
TGF-b signaling. Studies in avian models have also established
a strong requirement forWNT signaling for early NC specification
(Garcı´a-Castro et al., 2002). We activated Wnt signaling in our
system using the potent and cost-effective small molecule
CHIR99021 (Chir), which functions as an agonist of WNT
signaling by selectively inhibiting glycogen synthase kinase 3b
(GSK-3b; Meijer et al., 2004; Ring et al., 2003), although recom-
binant WNT also efficiently promoted NC induction (Figure S1).
The efficiency of NC induction wasmonitored with a Sox10::GFP
hESC reporter line (Chambers et al., 2012), which marks early
multipotent NC stem cells and specific NC derivatives, including
melanocyte progenitors.
We found that inhibition of BMP, TGF-b, and WNT signaling
pathways, collectively referred to as the NC-inductive (‘‘NC’’)
condition (Figure 1A), was sufficient to promote robust specifica-
tion of Sox10::GFP-expressing precursors (Figures 1B and 1C).52, April 25, 2013 ª2013 The Authors 1141
Compared with the standard DSi protocol, the NC-optimized
condition increased the yield of Sox10::GFP-positive cells by
>20-fold (53% ± 14%; Figure 1C). Induction of Sox10::GFP
occurred rapidly, with GFP expression first detectable by flow
cytometry at day 6 of differentiation and peaking by day 11 (Fig-
ure 1D). The ratio betweenCNS andNCdifferentiation was found
to be density dependent under DSi conditions, in agreement with
a previous study (Chambers et al., 2009), whereas density-
dependent differences in yield were less pronounced under NC
conditions (Figure S1). Efficient induction of Sox10::GFP corre-
lated with an increase in HNK-1 and p75 expression—two
markers that were previously found to define hESC-derived NC
populations (Lee et al., 2007). However, Sox10::GFP did not
exclusively colabel with HNK-1 and p75, suggesting that these
markers may not represent identical populations of NC (Fig-
ure S1). Specifically, the Sox10::GFP-positive population
contained p75 single-positive cells, whereas the Sox10::GFP-
negative population also included p75/HNK1 double-positive
cells. NC conditions did not support the emergence of ZO-1-ex-
pressing neural rosettes or CNS-associated PAX6 expression
(Elkabetz et al., 2008; Figure 1B). A comparative gene-expres-
sion analysis of day 11 DSi and NC cells further confirmed that
NC differentiation conditions favored induction of NC-associ-
ated markers, including SOX10, TFAP2A/B, SNAI2, and
EDNRA/B, as well as genes associated with WNT (WNT3A and
LEF1) and Notch signaling (DLL3 and HEY2; Figure 1E; Table
S1), whereas DSi cells expressed high levels of genes associ-
ated with CNS (PAX6 and HES5) and forebrain state (OTX2
and LHX2). Fate-specific markers were also induced under
both NC and DSi conditions withBRN3A, an early marker of sen-
sory neurogenesis that is observed following NC differentiation.
Genes associated with pigmentation, such as tyrosinase-related
protein 1 (TYRP1) and dopachrome tautomerase (DCT), were
observed under DSi conditions, presumably due to the presence
of retinal pigment epithelium cells, which can be expanded under
DSi conditions (Figure S2), although DCT is also expressed in the
mouse forebrain (Steel et al., 1992). Unlike previously reported
NC populations derived from hESCs under stromal coculture
conditions (Lee et al., 2007), the NC-derived cells did not exhibit
high levels of HOX gene expression, suggesting that these cells
correspond to the HOX-negative NC lineage, which was previ-
ously shown to be particularly plastic (Creuzet et al., 2005; Le
Douarin et al., 2004). However, the A-P axial level, including
HOX gene expression, could be manipulated with the use of
caudalizing cues such as FGF2 or retinoic acid (RA) treatment
(Figure S1).
NC Induction Is Driven by a Narrow Window of GSK-3b
Inhibition
To further investigate the individual contributions of the BMP,
TGF-b, and GSK-3b inhibitors to NC specification, we performed
timed withdrawal experiments during the 11 day differentiation
or omitted factors entirely (Figures 2A–2C). Although a brief
treatment with LDN was required for Sox10::GFP induction,
2–3 days of treatment appeared to be sufficient for optimal NC
specification. These findings contrast with a recent report in
which treatment with Noggin, another BMP inhibitor used in
the original DSi protocol, was found to be dispensable for the1142 Cell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authorsinduction of a p75+/HNK1+ NC population (Menendez et al.,
2011). We observed similar requirements for TGF-b/Activin inhi-
bition. Conditions in which the inhibitor SB was omitted entirely
were not permissive for NC differentiation, whereas withdrawal
at any point after day 4 allowed for robust Sox10::GFP induction
(Figure 2B). Continued treatment with either the BMP or TGF-b
inhibitors for the entire 11 days of differentiation did not nega-
tively impact theSox10::GFP yield, suggesting that derepression
of endogenous BMP or TGF-b signaling is not essential for trig-
gering NC differentiation (Figures 2A and 2B).
Whenwe investigated the requirements forWNT activation us-
ing the small molecule Chir, we observed a narrow window dur-
ingwhich Chir treatment was essential forSox10::GFP induction.
Although Chir exposure starting at day 2 of the differentiation re-
sulted in optimal Sox10::GFP induction, changing the onset of
Chir treatment by as little as 2 days resulted in a near-complete
loss of Sox10::GFP expression (Figure 2C). When we investi-
gated the minimal duration of WNT activity required for
Sox10::GFP induction, we found that a single day of Chir treat-
ment was sufficient to achieve 70% of the maximal yield (Fig-
ure 2D). To test whether a short pulse of Chir treatment could
induce a subsequent wave of endogenous WNT signaling, we
performed luciferase-based WNT reporter assays. We observed
that b catenin levels remained elevated 3 days after a single day
pulse of Chir treatment, suggesting that endogenous WNT
signalingwas indeed triggered by brief Chir exposure (Figure S3).
However, blocking endogenous WNT signaling after 1 day of
Chir treatment using the axin-stabilizing small molecule XAV-
939 (XAV) did not affect the efficiency of NC induction (Figure S3).
Our data indicate that WNT signaling is not required beyond a
brief inductive pulse to specify NC fate.
We next performed a global gene-expression analysis to
determine which transcripts were regulated immediately after
Chir exposure (Figures 2E–2H). Within 24 hr of Chir addition,
the most upregulated gene was SP5, a transcription factor
downstream of WNT and beta-catenin signaling that has been
implicated in anterior-posterior patterning (Fujimura et al.,
2007; Weidinger et al., 2005). Upregulation of AXIN2 andWNT1
at 24 hr and 6 days after Chir addition further confirmed that
Chir treatment induces endogenous WNT signaling. In contrast,
SIX3, a negative regulator of WNT signaling that is required for
vertebrate forebrain development (Braun et al., 2003; Lagutin
et al., 2003; Lavado et al., 2008), and HESX1 and SOX3, two
additional forebrain markers, were suppressed following Chir
treatment (Figure 2E). By day 6 of the differentiation, the time
point whenSox10::GFP expression was first observed, induction
of various additional NC markers, including EDNRA, SOX10,
SNAI2, TFAP2A/B, FOXD3, SOX9, and PAX3 (Figure 2F), was
observed, whereas various CNS and forebrain markers were
suppressed (Figure 2F). By days 8 (Figure 2G) and 11 (Figure 2H),
more mature, cell-type-specific markers, including ASCL1,
EDNRB, andOLIG2, were upregulated. Our global transcriptome
profiling data therefore establish a model in which treatment
with the GSK-3b inhibitor Chir during the NC protocol first in-
duces a surge of WNT signaling, followed by markers of NC
specification and a subsequent neurogenic wave.
We next determined whether the surprisingly narrow window
during which WNT signaling drives NC specification reflects a
Figure 2. NC Induction Is Driven by aNarrow
Window of Wnt Activation
(A and B) BMP inhibitor LDN193189 (LDN) (A) and
TGF-b inhibitor SB431542 (SB) (B) were individu-
ally withdrawn at various time points within the
context of the NC protocol, and induction of
Sox10::GFP was assessed at day 11 by FACS.
(C and D) Treatment with GSK-3b inhibitor
CHIR99021 (Chir) was initiated (C) or withdrawn (D)
at various time points, and induction of
Sox10::GFP was assessed at day 11 by FACS.
Sox10::GFP induction efficiency is represented as
a percentage of total viable cells.
(E–H) The effects of Chir on gene expression at
days 3 (E), 6 (F), 8 (G), and 11 (H) were determined
by comparative microarray analysis of NC cells
derived in the presence (green) or absence (red) of
Chir. Bold genes represent the top five most
differentially regulated genes.
All error bars represent the SEM of at least three
independent experiments. See also Figure S3.unique temporal competence of the cells that respond to NC-
inductive WNT signaling. Our gene-expression analysis had
identified genes induced with 24 hr and 6 days of Chir treatment
(Figures 2E and 2F). We asked whether these genes would also
be inducedwhenChir treatment was delayed until day 4 of differ-
entiation, a time point that does not efficiently support NC spec-
ification (Figure 2C). We found that many of the genes that were
upregulated within 24 hr of Chir treatment, including those
known to be direct targets of WNT signaling, were not induced
when cells were treated with Chir at day 4 (Figure S3). In fact,
upon delayed Chir treatment, many Chir-responsive genes
were expressed at levels comparable to DSi conditions. Intrigu-Cell Reports 3, 1140–11ingly, levels of the negative WNT regulator
SIX3, which is usually downregulated
upon Chir treatment, remained elevated
with late Chir treatment. Induction of late
WNT-responsive genes was similarly lost
(Figure S3). These data indicate that cells
lose competency to NC-inductive WNT
signals and undergo a default anterior
neuroectodermal program.
Lineage Specification and Isolation
of NC-Derived Melanoblasts
To confirm the melanocyte competence
of our NC-derived cells, we identified a
subpopulation of presumptive melano-
blasts at day 11 of differentiation based
on coexpression of Sox10::GFP and mi-
crophthalmia-associated transcription
factor (MITF; Figure 3A). MITF-positive
cells lacking Sox10::GFP expression
were also observed, which may be due
to downregulation of the BAC reporter,
as we observed continued SOX10 protein
expression by immunofluorescence (see
Figure 5E). To prospectively identify andisolate melanoblasts from the heterogeneous population of NC
cells, we selected KIT (c-kit) as a putative cell-surface marker
of early melanocyte progenitors. KIT was previously identified
as uniquely marking the melanocyte-competent subfraction of
NC cells (Luo et al., 2003; Reid et al., 1995) and plays an impor-
tant role in melanocyte migration (Kunisada et al., 1998; Yoshida
et al., 1996), proliferation (Kunisada et al., 1998; Yoshida et al.,
1996), and maturation (Kunisada et al., 1998). Using fluores-
cence-activated cell sorting (FACS) analysis, we confirmed
that 9% ± 2% of the population at day 11 of differentiation coex-
pressed Sox10::GFP and c-kit, whereas 59% ± 3% expressed
only Sox10::GFP (Figure 3B).52, April 25, 2013 ª2013 The Authors 1143
Figure 3. C-kit and Sox10 Expression Can Be Used to Identify and Isolate Melanoblasts
(A) Melanocyte progenitors can be identified in day 11 NC protocol-derived populations by coexpression of Sox10::GFP and the melanocyte transcription factor
MITF (arrowheads). Scale bar represents 50 mm.
(B) Flow cytometry reveals the presence of a Sox10::GFP and c-kit coexpressing population. C-kit ‘‘fluorescence minus one’’ (FMO) was used as a gating control
for c-kit staining.
(C) Four-way FACS for Sox10::GFP and c-kit reveals an enrichment of the melanocyte markers MITFM and Dct in the SOX10/c-kit double-positive population by
quantitative RT-PCR (qRT-PCR).
All error bars represent the SEM of at least three independent experiments. See also Figure S4.Purified Sox10::GFP, c-kit coexpressing (GFP+/cKit+) cells
expressed higher levels of the melanocyte markers MITF-M
and DCT when compared with GFP+/cKit cells (Figure 3C),
confirming the utility of KIT and Sox10 coexpression as an
appropriate strategy for melanoblast isolation. We performed a
candidate screen for factors that increase the percentage of
GFP+/cKit+ cells. Contrary to predictions based on literature in
other model systems, SCF signaling at this time point did not in-
crease melanoblast numbers; however, we identified BMP and
Endothelin 3 (EDN3) as two factors that did enhance
melanoblast yield when introduced at day 6 of differentiation
(Figure S4). The role of BMP signaling during melanocyte spec-
ification has been well established (Nissan et al., 2011; Thomas
and Erickson, 2008), and endothelins have been implicated in
the maintenance and proliferation of melanocyte precursors
(Baynash et al., 1994; Dupin and Le Douarin, 2003; Lahav
et al., 1996; Reid et al., 1996). Combined treatment with both
BMP4 and EDN3 (hereafter referred to as the ‘‘BE’’ condition)
significantly increased the percentage of GFP+/cKit+ cells to
37% ± 3% (Figure 4A). We observed robust expression of
SOX10,KIT,MITF-M, andDCTwithin theGFP+/cKit+ population
under both NC (Figure 3C) and BE (Figure S5) conditions. How-
ever, BE-derived melanoblasts expressed significantly higher1144 Cell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authorslevels of MITF-M and DCT than the same population derived
with the NC protocol (Figure 4B), suggesting that treatment
with BMP4 and EDN3 not only enhances melanoblast yield but
also further drives their maturation. A comparison of the relative
proportions of Sox10::GFP- and KIT-expressing populations
following NC and BE treatment revealed that BE conditions
increased the yield of double-positive melanocyte progenitors,
whereas the percentage of Sox10::GFP single-positive NC was
reduced (Figure 4C). However, the percentage of double-nega-
tive cells (GFP/cKit) remained unchanged. This change in
population makeup could be due to a direct fate switch within
the existing NC population. However, we cannot rule out the
possibility that increased proliferation of existing melanoblasts
or inhibition of nonmelanocyte NC contributes to the BE-medi-
ated increase in melanocyte precursors. Comparative global
gene-expression profiling of cell populations derived with the
NC and BE protocols confirmed the enhanced expression of
various melanocyte-associated markers, including TYRP1,
MLANA, DCT, TYR, and SILV, following treatment with BE (Fig-
ures 4D and S5). In contrast, NC-derived populations displayed
a gene-expression profile associated with sensory and nocicep-
tor neuron fates (Chambers et al., 2012). BE treatment also
induced substantial upregulation of COL3A1 and CRYAA
Figure 4. Treatment with BMP4 and EDN3
Enhances Melanoblast Specification
(A) Additional treatment with BMP4 and EDN3 (BE)
beginning at day 6 significantly enhances the yield
of Sox10::GFP, c-kit double-positive melanocyte
progenitors (n = 4, p = 0.0005).
(B) BE-derived melanocyte progenitors express
significantly higher levels of MITF and DCT than
NC-derived cells by qRT-PCR (n = 3; p = 0.03
[MITF], p = 0.05 [DCT]).
(C) BE treatment increases the yield of
Sox10::GFP, c-kit double-positive melanocyte
progenitors at the expense of Sox10::GFP single-
positive NC cells.
(D) Comparative gene-expression analysis identi-
fied significantly upregulated (red) and down-
regulated (orange) genes at day 11 in BE-induced
cells compared with NC cells. Bold genes repre-
sent the top ten most differentially regulated
genes.
(E) BE-derived melanocyte progenitors exhibit
spindle-like melanocyte morphology.
Scale bars represent 50 mm. All error bars repre-
sent the SEM of at least three independent ex-
periments. *p < 0.05. See also Figure S5.(Figure 4D). Our group previously observed transient expression
of COL3A1 and several crystallin transcripts in neural rosette-
stage cells (Elkabetz et al., 2008). However, future studies are
required to address whetherCOL3A1 andCRYAA are expressed
in NC-stage melanocyte precursors or represent contamination
with another cell type induced under BE conditions, as those
gene expression analyses were performed on unpurified BE
bulk populations. BE-derived Sox10::GFP cells that coex-
pressed MITF exhibited an elongated, spindle-like morphology
compatible with the appearance of melanocyte progenitors
(Figure 4E).
Maturation and Characterization of Melanocytes
Melanoblast progenitors were isolated on day 11 based on
Sox10::GFP and KIT expression and replated in maturation me-
dia (Figure 5A). We next established defined culture conditions
for melanocyte maturation. A previous melanocyte differentia-
tion medium was based on the use of conditioned media from
aWNT3A-producing murine cell line (Fang et al., 2006). Although
we found the same media to be sufficient for maturation of BE-
derived melanoblasts to a pigmented, terminally differentiated
state (Figure S6), we developed defined maturation conditions
using a medium containing SCF, EDN3, FGF2, Chir, cyclic
AMP, BMP4, and B27 (Figure S6). Under these conditions, pig-
mented cells were first observed by bright-field microscopy
6 days after sorting and coexpressed the melanocyte marker
MITF (Figure 5B). By day 20 of differentiation, most clusters
were pigmented (Figure 5C) and cell pellets became darkly
colored by passage 5 (Figure 5D). Extended culture supported
the propagation of an essentially pure population of melanocytes
expressing typical melanocyte transcription factors, such as
MITF and SOX10, and melanosomal markers, such as tyrosi-Cnase-related protein 1 (TYRP1) and premelanosome protein
(PMEL; Figures 5E and S6). A comparison of gene-expression
profiles of mature melanocytes and day 11 melanoblast progen-
itors revealed that maturation had supported the induction of
several late-stage melanocyte markers, including oculocutane-
ous albinism II (OCA2), tyrosinase (TYR), and melan-A (MLANA),
whereas NC markers such as TFAP2C, EDNRA, and EDN1 had
been downregulated (Figure 5F).
Electron microscopy (EM) of human ESC-derived melano-
cytes (ESC-melanocytes) revealed the presence of numerous
pigmented melanosomes, representing all four stages of mela-
nosome maturation (Figure 5G). In primary skin, melanocytes
reside at the basement membrane at the interface of the
epidermal and dermal layers. In an organotypic skin reconstruct
assay in which melanocytes and keratinocytes were seeded
onto a preformed layer of fibroblasts and collagen, ESC-melano-
cytes phenocopied the localization of primary control melano-
cytes and correctly homed to the basement membrane (Fig-
ure 5H). The gene-expression profiles of ESC-melanocytes
were more similar to adult than neonatal primary melanocytes
(Figure S6), although ESC-melanocytes differed from both pop-
ulations in their lack of Hox gene expression. It is possible that
patterning conditions for BE-derived melanocytes specify a
more anterior population of melanocytes as compared with pri-
mary cells isolated from posterior regions such as breast,
abdominal, and foreskin tissues. However, caudal melanocytes
expressing HoxB2 and HoxB4 could be established fromprecur-
sors treated with RA during the early stages of differentiation
(Figure S6). ESC-derivedmelanocytes also uniquely upregulated
genes associated with protein localization and transport (Fig-
ure S6), perhaps reflecting the increased melanin production
observed in comparison with primary melanocytes.ell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authors 1145
Figure 5. hESC-Derived Melanoblasts Can Be Matured to a Functional Pigmented State
(A) BE-derived melanocyte progenitors can be matured to a pigmented state following culture in media containing SCF, EDN3, FGF2, BMP, cAMP, and WNT
signaling factors.
(B) Pigmented cells expressing MITF can be observed as early as 1 week after passaging. Scale bar represents 20 mm.
(C and D) Cells become progressively more pigmented, with macroscopic pigmented clusters discernible in tissue culture wells within 3 weeks (C) and cell pellets
of 1 3 106 cells taking on a darkly pigmented phenotype (D).
(E) Extended culture supports the propagation of nearly pure populations of mature melanocytes expressing the transcription factors SOX10 and MITF, and
melanosomal markers TYRP1 and PMEL. Scale bar represents 50 mm.
(F) Mature melanocytes exhibit elevated levels of mature marker expression (red) and downregulation of NC- and SC-associated markers (blue) compared with
melanocyte progenitors in gene-expression analyses. Bold genes represent the top five most differentially regulated genes.
(G) Numerous pigmented melanosomes, representing all four stages of melanosome maturation (stages I–IV), are visible in the cytoplasm of ESC-derived
melanocytes by EM. Scale bar represents 5 mm (left) and 500 nm (right).
(H) Tyrosinase-positive (IHC brown) ESC-derived melanocytes home to the basement membrane in organotypic artificial skin reconstructs. Scale bar represents
5 mm. Left: no melanocyte negative control; middle: primary melanocytes; right: ESC-melanocytes.
See also Figure S6.Temporal analysis of Sox10::GFP and KIT expression during
NC induction showed that Sox10::GFP-expressing cells could
be detected by day 6 of differentiation (Figure 1D), whereas
Sox10::GFP, c-kit coexpressing cells did not emerge before
day 10 (Figure S4). To test the competency of Sox10-positive
cells to give rise to c-kit+ melanoblasts, we isolated Sox10::GFP
and KIT single-positive cells (GFP+/cKit and GFP/cKit+,1146 Cell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authorsrespectively), as well as double-positive and double-negative
cells, by flow cytometry and replated each in maturation media.
The cells were again assayed for Sox10::GFP and c-kit expres-
sion after 5 and 12 days. As predicted, GFP+/cKit cells gave
rise to GFP+/cKit+ and GFP/cKit+ progeny, while GFP cells
lacked this plasticity (Figure S5). More importantly, the GFP+/
cKit and GFP/cKit+ populations eventually differentiated
into MITF-expressing pigmented cells (Figure S5), although
GFP+/cKit cells did so with delayed kinetics. Meanwhile, the
GFP/cKit population never gave rise to pigmented cells and
could not be propagated in our maturation media. These data
illustrate that, even without sorting for SOX10 or KIT, BE-treated
cells can efficiently generate melanocytes under our defined
maturation conditions, which will greatly facilitate studies in
hESCs lacking a SOX10 reporter or in disease-specific iPSCs.
Modeling Melanosome Formation and Trafficking
Defects Using iPSC-Derived Melanocytes
We next determined whether iPSC-derived melanocytes could
be used to model genetic pigmentation defects. We selected
two subgroups of patients with diseases involving defects in
melanosome vesicle formation and trafficking: Hermansky-Pu-
dlak syndrome (HP) and Chediak-Higashi syndrome (CH). HP
encompasses eight autosomal-recessive disorders defined by
deficiencies in the biogenesis of lysosome-related organelles,
including melanosomes (Oh et al., 1996; Wei, 2006; Figure 6A).
Patients present with a range of symptoms, including oculocuta-
neous albinism, platelet storage disease, and, depending on the
disease subtype, immune deficiency and pulmonary fibrosis.
One of the patients used in this study had a mutation in the
HPS1 gene (HP1), and the other patient was deficient in
AP3B1 (HP2; Figure S7). CH is caused by a mutation in the lyso-
somal trafficking regulator (LYST) gene that results in the persis-
tence of abnormally large lysosome-related organelles (Karim
et al., 1997; Nagle et al., 1996; Figure S7). Due to their enlarged
size, melanosomes in CH patients cannot be efficiently trans-
ferred to neighboring keratinocytes, which leads to hypopigmen-
tation (Introne et al., 1999; Figure 6A).
We established three independent iPSC lines from each
patient and two control fibroblast donors using a single polycis-
tronic lentiviral vector expressing Oct4, Klf4, Sox2, and c-Myc
(Papapetrou et al., 2011; Table S2). The resulting iPSCs ex-
hibited an hESC-like morphology and expressed the pluripotent
transcription factors Oct4 and Nanog as well as the cell-surface
markers Tra-1-60, SSEA3, and SSEA4 (Figure S7). Mature mela-
nocytes expressing PMEL, SOX10, TYRP1, and MITF were
derived at comparable efficiencies from each of the patient
and control iPSC clones using the BE differentiation protocol
(Figures 6B and S7), further illustrating the robustness of our
differentiation protocol. Due to the selective growth of melano-
cytes in our maturation media, it was not necessary to select
cells for KIT or SOX10 expression at the melanoblast stage to
obtain essentially pure populations of iPSC-derived melano-
cytes (Figure S5). All of the HP2 iPSC-derived melanocytes ex-
hibited a near-complete loss of pigmentation both at the macro-
scopic level andwhen quantified after cell lysis, whereas the HP1
melanocytes exhibited a more subtle phenotype that was
detectable only after quantification (Figures 6C and 6D). CH me-
lanocytes exhibited pigmentation levels lower than those
observed with an African American control (control 1) but com-
parable to those observed with a Caucasian control (control 2;
Figures 6C and 6E), which is compatible with the hypothesis
that CH affects melanosome transfer rather than production. Dif-
ferences in pigmentation could also be assayed by FACS anal-
ysis, with higher levels of pigmentation correlating to higherCside scatter (SSC) values (Figures 6D and S7). All disease-related
phenotypes were consistent among melanocytes derived from
each of three independently derived iPSC clones, indicating
that disease behavior reflects genome-specific differences
rather than iPSC clonal variability.
The nature of the individual pigmentation defects was further
analyzed at the EM level, with HP1- and HP2-derived melano-
cytes exhibiting a notable reduction in mature melanosomes
(Figure 6F) as quantified by computer-assisted image analysis
(Figures 6G–6J). There was a significant decrease in the ratio
of melanosome to total cell area when compared with both
the C1 and C2 controls (Figures 6F and 6J). At higher magnifica-
tion, numerous dark punctae that may correspond to free
melanin in the cytoplasm were also discernible in HP2 cells (Fig-
ure 6F). In contrast, CH melanocytes exhibited the most striking
phenotype, with significant increases in both melanosome num-
ber and size (Figures 6G–6J). Increased melanosome number
and size was further corroborated by immunofluorescence
staining for the early melanosomal marker PMEL (Figure 6B).
High-magnification EM analysis revealed that the CH-derived
melanocytes exhibited mature but strikingly enlarged melano-
somes that were not seen in the melanocytes derived from
any of the other disease or control lines (Figure 6F). Global
gene-expression analyses in which control- and disease-
derived melanocytes were compared revealed few differences
at the transcript level (Figure S7). This likely reflects the biolog-
ical nature of these diseases, in which downstream processes
are disrupted with little opportunity for transcriptional feedback.
These data also again highlight the robust nature of our differen-
tiation protocol in which clones derived independently from con-
trol and disease lines clustered together with high degrees of
similarity.
Taken together, our data establish the derivation of melano-
cytes fromhPSCs as a robust protocol for studying lineage spec-
ification of NC and melanocyte lineages, and as a platform for
studying pigmentation-related disorders in patient-specific
PSCs (Figure 7).
DISCUSSION
The specification of NC during mouse and chick development is
dependent on both WNT and intermediate levels of BMP
signaling generated by neighboring nonneural ectoderm and
mesodermal tissues (Garcı´a-Castro et al., 2002; Kle´ber et al.,
2005; LaBonne and Bronner-Fraser, 1998; Marchant et al.,
1998; Patthey et al., 2008). However, the requirement for BMP
signaling is preceded in Xenopus models by an early need for
BMP inhibition to promote the robust acquisition of neural plate
identity, which in turn establishes the competence to respond to
subsequent NC inductive cues (LaBonne and Bronner-Fraser,
1998; Steventon et al., 2009). Although we were able to confirm
a similar requirement for early BMP inhibition in the induction of
human NC, surprisingly, we did not find that continued BMP
inhibition negatively impacted NC induction, even though
studies in chick and Xenopus embryos have implicated BMP
signaling during both NC induction and maintenance (Kle´ber
et al., 2005; Marchant et al., 1998; Selleck et al., 1998).
Our data are also distinct from previous observations inell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authors 1147
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Figure 7. Disease-Specific Melanocytes
that Faithfully Recapitulate Pigmentation
Defects Can Be Derived from hPSCs Using
a Stepwise Differentiation Paradigm
(A) Disease-specific fibroblasts from HP and CH
donors were reprogrammed to establish hPSCs.
(B) Exposure of Oct4- and Nanog-expressing
hPSCs to theWNT-activating NC protocol resulted
in the emergence of a Sox10-positive NC popu-
lation by day 6. Subsequent additional treatment
with BMP4 and EDN3 (BE) skewed the specifica-
tion along the melanocytic lineage to allow for the
establishment of a melanoblast progenitor popu-
lation expressing KIT and MITF at day 11. Further
maturation under ESC-melanocyte (ESC-mel)
conditions in the presence of WNTs, BMP4, and
cAMP supported induction of the late melanocyte
markers tyrosinase (TYR) and oculocutaneous
albinism II (OCA2). Mature melanocytes were used
to model the disease-specific pigmentation de-
fects of HP and CH.
(C) Growth conditions supporting each stage of
differentiation are summarized below.p75/HNK-1-expressing NC precursors derived from hESCs via a
rosette intermediate (Lee et al., 2007). Under those conditions,
there was a significant decrease in the percentage of putative
NC precursors following treatment with the BMP inhibitor noggin
and an increase following exposure to BMP4. These discrep-
ancies may reflect inherent differences in rosette- versus nonro-
sette-derived NC: the former reflects the stage of NC delamina-
tion, whereas the accelerated NC derivation conditions
presented here may represent an early NC induction stage prior
to the presence of a distinct neuroepithelial intermediate. Alter-
natively, as Sox10::GFP expression and p75/HNK-1 coexpres-
sion appear to identify overlapping but distinct NC populations,
it is possible that these two subtypes of NC may exhibit different
requirements for BMP signaling. It should be noted that a recent
immunohistochemical study of Carnegie stage 12–18 human
embryos found that HNK-1 labeled only a small subset of
migrating NC cells, whereas p75 expression also broadly labeled
non-NC populations (Betters et al., 2010). Future studies will be
required to dissect the exact contribution of BMP pathway ma-
nipulations during hESC differentiation to NC, and to define
whether differential requirements reflect distinct developmental
NC stages or subtypes.Figure 6. iPSC-Derived Melanocytes Recapitulate Disease-Associated
(A) HP and CH are disorders with defects in melanosome biogenesis and traffick
(B) Melanocytes derived from patient-specific and control (C1 and C2) iPSCs exp
Scale bar represents 50 mm.
(C) Cell pellets of HP2-derived melanocytes exhibit a near lack of pigmentation,
(D) Pigmentation levels of patient-specific melanocytes are correlated to granula
(E) Melanin content was determined from the absorbance of cell lysates at 475 n
(F) HP1- and HP2-associated pigmentation defects can be observed in electron
melanosomes. Scale bars represent 5 mm (top row) and 1 mm (bottom row).
(G–J) Stereological quantification of melanosome phenotype observed in electro
Error bars represent the SEM from melanocytes derived from three independent
Figure S7.
CThe use of Chir in our protocol offers a simple and cost-effec-
tive strategy to activate WNT signaling during NC induction.
Although we were able to demonstrate robust induction of
Sox10::GFP upon exposure to high doses of WNT3a (Figure S1),
the concentrations of WNT3a required were cost prohibitive and
not practical for routine NC induction. Chir treatment triggers
rapid activation of WNT signaling pathway molecules and robust
induction of a TCF::luciferase reporter (Figure S1). The critical
role of WNT signaling in our NC-induction conditions is consis-
tentwith previous findings in avian systems,which demonstrated
that WNT signaling is necessary and sufficient for NC induction
(Garcı´a-Castro et al., 2002). Similar requirements for WNT
signaling to induce a p75, HNK-1 coexpressing human NC pop-
ulation have also been reported (Lee et al., 2007;Menendez et al.,
2011); however, our study is unique in addressing the temporal
requirements for WNT signaling during human NC specification.
The very narrow window during which WNT signaling promoted
Sox10::GFP induction was unexpected and offers a powerful
tool to mechanistically define competency factors that act
together with WNT in NC specification. One interesting hypothe-
sis is that loss of competency correlates with the time course of
Dkk1 induction and anterior CNS fate specification observedPigmentation Defects
ing amenable for iPSC-based disease modeling.
ress melanocyte-associated transcription factors and melanosomal proteins.
whereas HP1-derived melanocytes exhibit a more subtle defect.
rity (SSC) in flow-cytometric analysis.
m.
micrographs, and CH-derived melanocytes exhibit disease-typical enlarged
n micrographs.
iPSC lines for each disease (two lines were derived from donor C2). See also
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during DSi (Fasano et al., 2010). This is supported by our own
observation that the negative WNT regulator SIX3 continued to
be expressed when Chir treatment was not initiated until day 4.
It is tempting to speculate that knockdown of SIX3 may restore
NC competence to cells at this late time point. Furthermore, it
was recently reported that sequential activation ofWNT signaling
in the mouse embryo affects NC lineage specification, particu-
larly along sensory neuronal and melanocyte lineages (Hari
et al., 2012). It will be interesting to define whether SOX10::GFP
NCcells induced following aChir pulse treatment are functionally
distinct from those generated upon long-term Chir treatment,
particularly under conditions in which endogenous WNT
signaling is further suppressed by treatment with XAV.
Our study also establishes a readily scalable, defined protocol
that generates pure populations of mature melanocyte with
great efficiency. Our cells recapitulate all of the structural fea-
tures of wild-type melanocytes, making them suitable for a
wide range of applications and future studies. In particular, the
remarkable fidelity of our cells in capturing the different levels
of pigmentation in Caucasian- and African-American-derived
melanocytes highlights the potential utility of these cells in other
fields, such as the cosmetics industry. Furthermore, this proto-
col allows for the stage-specific isolation of melanocyte progen-
itors and mature melanocytes. This will be of particular interest
in studies investigating melanocyte development and malignant
transformation. We also demonstrate that the axial levels of NC
and melanocyte precursor populations can be readily patterned
using caudalizing FGF and RA cues. The ability to derive Hox-
positive versus Hox-negative human NC cells is particularly
intriguing because it will enable studies of the unique plasticity
reported for Hox-negative NC in the avian system (Le Douarin
et al., 2004).
A recent study also identified Schwann cell precursors as an
additional source of melanocytes (Adameyko et al., 2009), and
EDN3 has been shown to induce the reversion of melanocytes
to a bipotent progenitor (Dupin et al., 2000). It will be interesting
to further explore this close association between glial and mela-
nocyte fates, although the reported expression of Schwann-cell-
associated markers in murine melanoblasts (Colombo et al.,
2012) highlights the need for a thorough and careful analysis to
differentiate between the origin of melanocytes from a bipotent
glial-melanocyte progenitor and the derivation of melanocytes
from Schwann cell precursors.
The derivation of PSCs from human fibroblasts (Park et al.,
2008a; Takahashi et al., 2007; Yu et al., 2007) has been success-
fully applied to model human diseases (Dimos et al., 2008; Ebert
et al., 2009; Park et al., 2008b), including disorders of the NC
such as familial dysautonomia (Lee et al., 2009). In this study,
we present an example of the modeling of melanocyte-associ-
ated disorders through derivation of patient-specific iPSCs
from three distinct genetic syndromes. In each case, we were
able to successfully generate patient-specific melanocytes and
define pigmentation defects characteristic of each disorder
in vitro. Previous iPSC-based disease modeling studies suffered
greatly from variability observed between iPSC lines. Therefore,
the unusual degree of fidelity we observed between melanocyte
clones derived from multiple iPSC lines illustrates the highly
robust nature of our melanocyte induction protocol. This estab-1150 Cell Reports 3, 1140–1152, April 25, 2013 ª2013 The Authorslishes a framework for high-throughput screening studies to
further explore disease biology or to identify novel candidate
drugs affecting melanocyte specification or levels of pigmenta-
tion. A particularly attractive future strategy would be to use
disease-specific melanocytes to identify drugs that can reverse
easily screened pigmentation defects associated with HP1 as
a surrogate assay for compounds that might also correct
lysosomal function in other disease-relevant cell types, such as
pulmonary pneumocytes.
Our study offers insights into the precise signaling require-
ments for early NC induction, melanocyte lineage specification,
and melanocyte maturation. These insights can now be har-
nessed to establish unlimited numbers of melanocytes suitable
for a broad range of applications, including a model system for
the study of melanocyte pathologies and malignant melanoma
origination.EXPERIMENTAL PROCEDURES
NC and Melanocyte Differentiation
Neural induction using the DSi protocol was performed as previously
described (Chambers et al., 2009, 2011; Lee et al., 2010). Briefly, dissociated
hESCs and iPSCs were plated on matrigel at a density of 18,000–
25,000 cells/cm2 in MEF-conditioned hESC medium containing 10 ng/ml
FGF2 and 10 mM ROCK-inhibitor (Y-27632). Cells were allowed to reach
70%–80% confluence over 3 days. Differentiation was initiated by switching
to medium that included knockout serum replacement medium with 500 nM
LDN193189 (Stemgent) and 10 mM SB431542 (Tocris). Beginning at day 4,
the knockout serum replacement medium was gradually replaced with
increasing amounts of N2 medium. For NC differentiation, the DSi protocol
was adapted by treating with 3 mM CHIR99021 (Stemgent) beginning on day
2 and withdrawing LDN193189 and SB431542 at days 3 and 4, respectively.
BE-derived cells were additionally treated with 25 ng/ml BMP4 and 100 nM
EDN3 beginning at day 6 of differentiation. Cells were collected on day 11
for analysis or passaging.
Melanocyte Maturation and Maintenance
Day 11 dissociated BE-derived cells were replated on poly-ornithine, laminin,
and fibronectin-coated plates in Neurobasal (NB; Invitrogen)/Mel medium. The
NB/Mel medium was prepared by replacing the WNT3A-CM component in
Mel-1 medium (Fang et al., 2006) with NB medium containing 2% B27
supplement (Invitrogen), 3 mM Chir, 25 ng/ml BMP4, and 500 mM dbcAMP.
Cells were fed every other day and passaged weekly for maintenance and
expansion.
Pigmentation Quantification
Melanin content was quantified by previously described methods (Friedmann
andGilchrest, 1987;Wen-Jun et al., 2008). Briefly, 2.53 105melanocyteswere
collected and pelleted at 16,000 3 g for 30 s. Cells were washed twice with
PBS and then dissolved in 250 ml 1M NaOH for 40 min at 37C. Then 100 ml
of cell lysate was transferred in duplicate to 96-well plates and the OD475
was measured with a PerkinElmer EnSpire plate reader.
Organotypic Skin Reconstruct
Organotypic skin reconstructs were established as previously described
(Meier et al., 2000). Briefly, an artificial dermal layer was established by seeding
human dermal fibroblasts (Invitrogen) in collagen in transwell permeable sup-
ports (Corning). After several days, human epidermal keratinocytes and pri-
mary (control) or ESC-derived melanocytes were introduced on top of the
dermal layer and allowed to expand and stratify at the air-liquid interphase
for an additional 2 weeks. Skin reconstructs were collected, fixed in 10%
formalin, and embedded in paraffin for sectioning and immunohistochemical
processing.
For further details regarding the materials and methods used in this work,
see Extended Experimental Procedures.
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